Revisão Acesso aberto Revisado por pares

Recent developments in anti-herpesvirus drugs

2013; Oxford University Press; Volume: 106; Issue: 1 Linguagem: Inglês

10.1093/bmb/ldt011

ISSN

1471-8391

Autores

Hugh J. Field, R. Anthony Vere Hodge,

Tópico(s)

Viral-associated cancers and disorders

Resumo

BackgroundHerpesviruses notably establish lifelong infections, with latency and reactivation. Many of the known human herpesviruses infect large proportions of the population worldwide. Treatment or prevention of herpes infections and recurrent disease still pose a challenge in the 21st century.

Referência(s)